|
Volumn 17, Issue 9, 2009, Pages 3499-3507
|
Asymmetric synthesis and biological evaluation of Danshensu derivatives as anti-myocardial ischemia drug candidates
|
Author keywords
Asymmetric synthesis; Danshensu derivatives; Myocardial infarction; Neonatal rat ventricular myocytes (NRVMs)
|
Indexed keywords
2 ACETAMIDO 3 (3,4 DIACETYLPHENYL)ACRYLIC ACID;
2 ACETAMIDO 3 (3,4 METHYLENEDIOXYPHENYL)ACRYLIC ACID;
2 ACETOXY 3 (3,4 DIACETOXYPHENYL)ACRYLIC ACID;
2 ACETOXY 3 (3,4 DIHYDROXYPHENYL)ACRYLIC ACID;
2 ACETOXY 3 (3,4 METHYLENEDIOXYPHENYL)ACRYLIC ACID;
2 ACETOXY 3 (3,4 METHYLENEDIOXYPHENYL)PROPANOIC ACID;
3 (3,4 DIHYDROXYPHENYL) 2 HYDROXYACRYLIC ACID;
3 (3,4 DIHYDROXYPHENYL)LACTIC ACID;
3 (3,4 METHYLENEDIOXYPHENYL) 2 HYDROXYACRYLIC ACID;
3 (3,4 METHYLENEDIOXYPHENYL) 2 HYDROXYPROPANOIC ACID;
CASPASE 3;
METHYL 2 ACETOXY 3 (3,4 DIACETOXYPHENYL)PROPANOATE;
METHYL 2 ACETOXY 3 (3,4 DIACETYLPHENYL)ACRYLATE;
METHYL 2 ACETOXY 3 (3,4 METHYLENEDIOXYPHENYL) ACRYLATE;
METHYL 2 ACETOXY 3 (3,4 METHYLENEDIOXYPHENYL) PROPANOATE;
METHYL 2 ACETOXY 3 (3,4 METHYLENEDIOXYPHENYL)PROPANOATE;
PROTEIN BAX;
PROTEIN BCL 2;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ANTIOXIDANT ACTIVITY;
APOPTOSIS;
ARTICLE;
CELL DAMAGE;
CELL VIABILITY;
CONTROLLED STUDY;
DRUG ACTIVITY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
HEART MUSCLE ISCHEMIA;
HYDROGENATION;
HYPOXIA;
MALE;
MUSCLE CELL;
NONHUMAN;
PROTEIN EXPRESSION;
RAT;
ANIMALS;
CARDIOTONIC AGENTS;
CASPASE 3;
CELL HYPOXIA;
CELL SURVIVAL;
CELLS, CULTURED;
HEART;
HUMANS;
LACTATES;
MYOCARDIAL INFARCTION;
MYOCARDIAL ISCHEMIA;
MYOCARDIUM;
MYOCYTES, CARDIAC;
RATS;
RATS, SPRAGUE-DAWLEY;
STEREOISOMERISM;
RATTUS;
|
EID: 65249176910
PISSN: 09680896
EISSN: None
Source Type: Journal
DOI: 10.1016/j.bmc.2009.02.065 Document Type: Article |
Times cited : (44)
|
References (24)
|